DRUG Valuation
Bright Minds Biosciences Inc
$
32.720
- Overview
- Forecast
- Valuation
DRUG Relative Valuation
DRUG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DRUG is overvalued; if below, it's undervalued.
Historical Valuation
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
5.50
P/B
Median3y
8.59
Median5y
7.43
-0.89
FCF Yield
Median3y
-52.59
Median5y
-38.51
Competitors Valuation Multiple
The average P/S ratio for DRUG's competitors is 24.58, providing a benchmark for relative valuation. Bright Minds Biosciences Inc Corp (DRUG) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
Revenue Growth
Market Cap
People Also Watch
MLAB
Mesa Laboratories Inc
112.550
USD
-2.57%
CRML
Critical Metals Corp
2.260
USD
+5.12%
LAC
Lithium Americas Corp
2.670
USD
+1.52%
XPOF
Xponential Fitness Inc
7.565
USD
+0.87%
ASTE
Astec Industries Inc
33.928
USD
-1.60%
ARKO
Arko Corp.
3.960
USD
-0.50%
PLYM
Plymouth Industrial REIT Inc
14.105
USD
-0.32%
SHLS
Shoals Technologies Group Inc
3.350
USD
+1.82%
MEG
Montrose Environmental Group Inc
14.350
USD
+1.13%
GSM
Ferroglobe PLC
3.405
USD
+0.74%
FAQ
Is Bright Minds Biosciences Inc (DRUG) currently overvalued or undervalued?
Bright Minds Biosciences Inc (DRUG) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Bright Minds Biosciences Inc (DRUG) is between to according to relative valuation methord.
What is Bright Minds Biosciences Inc (DRUG) fair value?
How does DRUG's valuation metrics compare to the industry average?
What is the current P/B ratio for Bright Minds Biosciences Inc (DRUG) as of Apr 16 2025?
What is the current FCF Yield for Bright Minds Biosciences Inc (DRUG) as of Apr 16 2025?
What is the current Forward P/E ratio for Bright Minds Biosciences Inc (DRUG) as of Apr 16 2025?